Abstract
Objective: We sought to examine outcomes of mifepristone and misoprostol for early pregnancy failure (EPF) treatment in a nonresearch setting. Study Design: A protocol was developed for physicians to use mifepristone 200 mg orally and misoprostol 800 μg vaginally for EPF. Success rates were analyzed and an adjusted multivariable regression was used to identify factors predictive of success. Results: Treatment success occurred in 99 (80%; 95% confidence interval, 7287%) of 123 patients after mifepristone and a single dose of misoprostol and 102 (83%; 95% confidence interval, 7589%) patients overall. The odds of successful medical treatment were increased in women with a diagnosis of intrauterine embryonic/fetal demise (odds ratio, 3.80) and decreased in women who made additional emergency department visits (odds ratio, 0.12). Conclusion: Patients and clinicians may be more likely to intervene surgically with an EPF when a strict study protocol is not being followed.
| Original language | English (US) |
|---|---|
| Journal | American Journal of Obstetrics and Gynecology |
| Volume | 204 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2011 |
| Externally published | Yes |
Fingerprint
Keywords
- early pregnancy failure
- mifepristone
- misoprostol
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Mifepristone and misoprostol for early pregnancy failure : A cohort analysis. / Kollitz, Kathleen M.; Meyn, Leslie A.; Lohr, Patricia A.; Creinin, Mitchell D.
In: American Journal of Obstetrics and Gynecology, Vol. 204, No. 5, 05.2011.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Mifepristone and misoprostol for early pregnancy failure
T2 - A cohort analysis
AU - Kollitz, Kathleen M.
AU - Meyn, Leslie A.
AU - Lohr, Patricia A.
AU - Creinin, Mitchell D
PY - 2011/5
Y1 - 2011/5
N2 - Objective: We sought to examine outcomes of mifepristone and misoprostol for early pregnancy failure (EPF) treatment in a nonresearch setting. Study Design: A protocol was developed for physicians to use mifepristone 200 mg orally and misoprostol 800 μg vaginally for EPF. Success rates were analyzed and an adjusted multivariable regression was used to identify factors predictive of success. Results: Treatment success occurred in 99 (80%; 95% confidence interval, 7287%) of 123 patients after mifepristone and a single dose of misoprostol and 102 (83%; 95% confidence interval, 7589%) patients overall. The odds of successful medical treatment were increased in women with a diagnosis of intrauterine embryonic/fetal demise (odds ratio, 3.80) and decreased in women who made additional emergency department visits (odds ratio, 0.12). Conclusion: Patients and clinicians may be more likely to intervene surgically with an EPF when a strict study protocol is not being followed.
AB - Objective: We sought to examine outcomes of mifepristone and misoprostol for early pregnancy failure (EPF) treatment in a nonresearch setting. Study Design: A protocol was developed for physicians to use mifepristone 200 mg orally and misoprostol 800 μg vaginally for EPF. Success rates were analyzed and an adjusted multivariable regression was used to identify factors predictive of success. Results: Treatment success occurred in 99 (80%; 95% confidence interval, 7287%) of 123 patients after mifepristone and a single dose of misoprostol and 102 (83%; 95% confidence interval, 7589%) patients overall. The odds of successful medical treatment were increased in women with a diagnosis of intrauterine embryonic/fetal demise (odds ratio, 3.80) and decreased in women who made additional emergency department visits (odds ratio, 0.12). Conclusion: Patients and clinicians may be more likely to intervene surgically with an EPF when a strict study protocol is not being followed.
KW - early pregnancy failure
KW - mifepristone
KW - misoprostol
UR - http://www.scopus.com/inward/record.url?scp=79955597638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955597638&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2010.12.026
DO - 10.1016/j.ajog.2010.12.026
M3 - Article
C2 - 21306697
AN - SCOPUS:79955597638
VL - 204
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
SN - 0002-9378
IS - 5
ER -